[1]
2026. Navigating Sequencing in Relapsed/Refractory Multiple Myeloma: Canadian Experts Discuss the Evidence and the Evolving Options. Actualité hématologique au Canada. 5, s01 (févr. 2026), 2–9. DOI:https://doi.org/10.58931/cht.2026.5s0181.